Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 sequential therapy after Docetaxel + S-1 in stage III gastric cancer
NCT05813015Phase 3Recruiting
- Sponsor
- Zhejiang University
- Start
- Jan 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in gastric adenocarcinoma, sponsored by Zhejiang University. Started Jan 2023; status: recruiting.
02
Drugs
tegafur
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT05813015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05813015.